Evaluation of Physical Activity Practice (AP) After Cerebral Vascular Stroke (Stroke) (QAP-AVC)

Physical activity is defined by any movement produced by the skeletal muscles responsible for an increase in energy expenditure.

The Stroke Council of the American Heart Association (AHA) recommends, in prevention after the occurrence of a first stroke, the practice of moderate to intense physical activity for 40 minutes a day, three to four times a week (Lackland et al., 2014). The World Health Organization (WHO) also recommends the practice of at least 150 minutes of moderate-intensity endurance activity or at least 75 minutes of endurance activity of sustained intensity per week, adapted to the possibilities of the patient (World Health Organization 2010). Unfortunately, the majority of stroke patients have activity below recommendation (Rand et al., 2009).

The main hypothesis of this work is that the amount of AP, measured by self-questionnaire, is insufficient, and below current recommendations in patients with stroke, after return home.

Given the multiple physical, psychological, social, and economic benefits of PA practice, it is also important to identify the habits and challenges that patients experience with PA, so that they can be better informed. advise and guide them to reach AP stroke recommendations.

Study Overview

Status

Completed

Detailed Description

Physical activity is defined by any movement produced by the skeletal muscles responsible for an increase in energy expenditure. It brings many benefits after stroke, particularly in terms of secondary prevention by reducing modifiable risk factors, cardio-respiratory capacity, and neuromotive, cognitive and functional recovery by stimulating brain plasticity (Saunders et al., 2014).

The Stroke Council of the American Heart Association (AHA) recommends, in prevention after the occurrence of a first stroke, the practice of moderate to intense physical activity for 40 minutes a day, three to four times a week (Lackland et al., 2014). The World Health Organization (WHO) also recommends the practice of at least 150 minutes of moderate-intensity endurance activity or at least 75 minutes of endurance activity of sustained intensity per week, adapted to the possibilities of the patient (World Health Organization 2010). Unfortunately, the majority of stroke patients have activity below recommendation (Rand et al., 2009).

The main hypothesis of this work is that the amount of AP, measured by self-questionnaire, is insufficient, and below current recommendations in patients with stroke, after return home.

Given the multiple physical, psychological, social, and economic benefits of PA practice, it is also important to identify the habits and challenges that patients experience with PA, so that they can be better informed. advise and guide them to reach AP stroke recommendations.

Study Type

Observational

Enrollment (Actual)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Amiens, France
        • CHU Amiens Picardie

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

All other patients hospitalized in the department of Neurological MPR in the wake of a stroke, or who have been summoned to a post-stroke consultation by the Neurological MPR department of the University Hospital of Amiens, will initially be included.

Description

Inclusion Criteria:

  • Patients over 18 years of age when completing the questionnaire.
  • Have had ischemic or hemorrhagic stroke confirmed by MRI or CT scan.
  • Hospitalized in the Department of Neurological MPR of Amiens University Hospital, or having received a consultation in MPR at Amiens University Hospital after returning home.
  • Not institutionalized

Exclusion Criteria:

  • Patients over 18 years of age when completing the questionnaire.
  • Have had ischemic or hemorrhagic stroke confirmed by MRI or CT scan.
  • Hospitalized in the Department of Neurological MPR of Amiens University Hospital, or having received a consultation in MPR at Amiens University Hospital after returning home.
  • Not institutionalized

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
AP in the aftermath of a stroke
Time Frame: 36 month
The objective of this study is to Quantify the Physical Activity (PA) level to patients in the aftermath of a stroke after returning homeduring the rehabilitation treatment.
36 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Louis Doutrellot, MD, PhD, CHU Amiens

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 23, 2017

Primary Completion (Actual)

April 23, 2018

Study Completion (Actual)

April 23, 2018

Study Registration Dates

First Submitted

September 27, 2018

First Submitted That Met QC Criteria

September 27, 2018

First Posted (Actual)

September 28, 2018

Study Record Updates

Last Update Posted (Actual)

May 17, 2023

Last Update Submitted That Met QC Criteria

May 16, 2023

Last Verified

September 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cerebral Vascular Disorder

Clinical Trials on the Medical Program Information Systems (PMSI)

3
Subscribe